Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis

Patients with rheumatoid arthritis (RA) are at risk of excess mortality, predominantly owing to cardiovascular (CV) events. The receptor for advanced glycation end products (RAGE) has been implicated in the perpetuation of the chronic inflammatory response in vascular disease. A Gly82→Ser polymorphi...

Descripción completa

Detalles Bibliográficos
Autores principales: Carroll, Lisa, Frazer, Ian H, Turner, Malcolm, Marwick, Thomas H, Thomas, Ranjeny
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906817/
https://www.ncbi.nlm.nih.gov/pubmed/17425804
http://dx.doi.org/10.1186/ar2175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906817/
https://www.ncbi.nlm.nih.gov/pubmed/17425804
http://dx.doi.org/10.1186/ar2175

Ejemplares similares